WallStreetZenWallStreetZen

NASDAQ: DRTS
Alpha Tau Medical Ltd Stock

$2.56-0.10 (-3.76%)
Updated Apr 19, 2024
DRTS Price
$2.56
Fair Value Price
$0.04
Market Cap
$178.36M
52 Week Low
$2.55
52 Week High
$4.80
P/E
-6.1x
P/B
2.11x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$29.16M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.27
Operating Cash Flow
-$18M
Beta
0.37
Next Earnings
May 22, 2024
Ex-Dividend
N/A
Next Dividend
N/A

DRTS Overview

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how DRTS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

DRTS ($2.56) is overvalued by 6,911.74% relative to our estimate of its Fair Value price of $0.04 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
DRTS ($2.56) is not significantly undervalued (6,911.74%) relative to our estimate of its Fair Value price of $0.04 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
DRTS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more DRTS due diligence checks available for Premium users.

Be the first to know about important DRTS news, forecast changes, insider trades & much more!

DRTS News

Valuation

DRTS fair value

Fair Value of DRTS stock based on Discounted Cash Flow (DCF)
Price
$2.56
Fair Value
$0.04
Overvalued by
6,911.74%
DRTS ($2.56) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
DRTS ($2.56) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
DRTS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

DRTS price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-6.1x
Industry
15.81x
Market
40.51x

DRTS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.11x
Industry
5.74x
DRTS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

DRTS's financial health

Profit margin

Revenue
$0.0
Net Income
-$7.4M
Profit Margin
0%
DRTS's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$107.4M
Liabilities
$22.9M
Debt to equity
0.27
DRTS's short-term assets ($85.76M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DRTS's short-term assets ($85.76M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DRTS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
DRTS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

DRTS vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
DRTS$178.36M-3.76%-6.10x2.11x
GOSS$176.86M-2.73%-0.66x2.82x
OMER$176.73M-4.98%-1.62x-7.07x
KOD$176.43M-3.17%-0.68x0.66x
AEON$176.10M-28.75%7.17x-1.15x

Alpha Tau Medical Stock FAQ

What is Alpha Tau Medical's quote symbol?

(NASDAQ: DRTS) Alpha Tau Medical trades on the NASDAQ under the ticker symbol DRTS. Alpha Tau Medical stock quotes can also be displayed as NASDAQ: DRTS.

If you're new to stock investing, here's how to buy Alpha Tau Medical stock.

What is the 52 week high and low for Alpha Tau Medical (NASDAQ: DRTS)?

(NASDAQ: DRTS) Alpha Tau Medical's 52-week high was $4.80, and its 52-week low was $2.55. It is currently -46.67% from its 52-week high and 0.39% from its 52-week low.

How much is Alpha Tau Medical stock worth today?

(NASDAQ: DRTS) Alpha Tau Medical currently has 69,670,612 outstanding shares. With Alpha Tau Medical stock trading at $2.56 per share, the total value of Alpha Tau Medical stock (market capitalization) is $178.36M.

Alpha Tau Medical stock was originally listed at a price of $10.26 in Jan 15, 2021. If you had invested in Alpha Tau Medical stock at $10.26, your return over the last 3 years would have been -75.05%, for an annualized return of -37.04% (not including any dividends or dividend reinvestments).

How much is Alpha Tau Medical's stock price per share?

(NASDAQ: DRTS) Alpha Tau Medical stock price per share is $2.56 today (as of Apr 19, 2024).

What is Alpha Tau Medical's Market Cap?

(NASDAQ: DRTS) Alpha Tau Medical's market cap is $178.36M, as of Apr 20, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Alpha Tau Medical's market cap is calculated by multiplying DRTS's current stock price of $2.56 by DRTS's total outstanding shares of 69,670,612.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.